NASDAQ · Health care

Intelligent Bio Solutions Inc. (INBS)

Intelligent Bio Solutions Inc. reported revenue of $4.2M in fiscal 2026, up 38.1% from a year earlier. It posted a net loss of $12.4M. In fiscal 2026 capital spending exceeded operating cash flow by $12.1M. At June 30, 2026 it held $4M in cash. Its latest periodic report to the SEC is the annual report (10-K) filed on August 19, 2026.

Watch INBS in 60 seconds

Price

$1.70

-0.59% on the day · September 25, 2026

52-week range $1.52 to $24.90

Market cap

$4.1M

Revenue (FY2026)

$4.2M

+38.1% year on year

Net margin

-294.9%

What Intelligent Bio Solutions Inc. does

Intelligent Bio Solutions Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker INBS.

Revenue and profit by year

Revenue

Net income

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal year	Revenue	Operating income	Net income	Diluted EPS	Free cash flow
2026	$4.2M	-$12.6M	-$12.4M	-$8.44	-$12.1M
2025	$3.1M	-$10.7M	-$10.6M	-$20.04	-$9.9M
2024	$3.1M	-$10.3M	-$10.2M	-$63.93	-$9.8M
2023	$1.3M	-$12.6M	-$10.6M	-$1,272.54	n/a
2022	$437.1K	-$8.3M	-$8.3M	-$1,362.75	n/a
2021	$2M	-$5.6M	-$7M	-$81.79	n/a

Full financial statements: income, balance sheet and cash flow

Next report expected around November 25, 2026.

Estimated from its filing rhythm: about 98 days after its last report of August 19, 2026, its usual gap. Not a date the company has announced. See the report calendar

Where INBS ranks in Health care

Revenue$4.2M

#514 of 646 in Health care · Bottom 20%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Intelligent Bio Solutions Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

September 23, 2026
Securities offering prospectus 424B3
September 15, 2026
Shelf registration to sell securities S-3
September 11, 2026
Other event 8-K
September 9, 2026
Investor disclosure 8-K
September 2, 2026
Material agreement 8-K
September 1, 2026
Investor disclosure 8-K
August 28, 2026
Investor disclosure 8-K
August 19, 2026
Quarterly results 8-K
August 19, 2026
Annual report 10-K · period to June 30, 2026Revenue rose 38% to $4.2M versus the prior year; diluted EPS -$8.44 versus -$20.04.
August 14, 2026
Passive stake changed SCHEDULE 13G/A

Recent insider filings (Forms 3, 4 and 144): 10, the latest on March 20, 2026. Insider transactions on SEC

Who owns INBS

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

Holder	Of class	Shares	Filed
Armistice Capital, LLC13G, passive with 1 related filers	5.91%	141,397	August 14, 2026

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

We have not read this company's Form 4 filings yet.

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about INBS

What does Intelligent Bio Solutions Inc. do?

Intelligent Bio Solutions Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker INBS.

Is Intelligent Bio Solutions Inc. profitable?

No. In fiscal 2026 it reported a net loss of $12.4M on revenue of $4.2M.

How much revenue does Intelligent Bio Solutions Inc. make?

In fiscal 2026 Intelligent Bio Solutions Inc. reported revenue of $4.2M. That is 38.1% more than a year earlier.

When did Intelligent Bio Solutions Inc. last report?

Its most recent periodic report is the annual report (10-K) filed on August 19, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the securities offering prospectus from September 23, 2026.

Similar companies

Becton Dickinson & Co

BSX

Boston Scientific Corp

BAX

Baxter International Inc

Compare INBS with

Compare INBS with any company

Follow INBS

Get an email when Intelligent Bio Solutions Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow INBS: get an email when it files

Where the numbers come from

Financial figures are the values Intelligent Bio Solutions Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.